pLH-spsgRNA2 Citations (12)
Originally described in: Multicolor CRISPR labeling of chromosomal loci in human cells.Ma H, Naseri A, Reyes-Gutierrez P, Wolfe SA, Zhang S, Pederson T Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):3002-7. doi: 10.1073/pnas.1420024112. Epub 2015 Feb 23. PubMed Journal
Articles Citing pLH-spsgRNA2
| Articles |
|---|
| Deletion of transcription factor binding motifs using the CRISPR/spCas9 system in the beta-globin LCR. Kim YW, Kim A. Biosci Rep. 2017 Jul 20. pii: BSR20170976. doi: 10.1042/BSR20170976. PubMed |
| BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers. Kuznetsov JN, Aguero TH, Owens DA, Kurtenbach S, Field MG, Durante MA, Rodriguez DA, King ML, Harbour JW. Sci Adv. 2019 Sep 18;5(9):eaax1738. doi: 10.1126/sciadv.aax1738. eCollection 2019 Sep. PubMed |
Background-suppressed live visualization of genomic loci with an improved CRISPR system based on a split fluorophore.
Chaudhary N, Nho SH, Cho H, Gantumur N, Ra JS, Myung K, Kim H.
Genome Res. 2020 Sep;30(9):1306-1316. doi: 10.1101/gr.260018.119. Epub 2020 Sep 4.
PubMed
Associated Plasmids |
| GATA-1-dependent histone H3K27 acetylation mediates erythroid cell-specific chromatin interaction between CTCF sites. Kim YW, Kang Y, Kang J, Kim A. FASEB J. 2020 Nov;34(11):14736-14749. doi: 10.1096/fj.202001526R. Epub 2020 Sep 14. PubMed |
| The human beta-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites. Kim J, Kang J, Kim YW, Kim A. FASEB J. 2021 Jun;35(6):e21669. doi: 10.1096/fj.202002337R. PubMed |
| Histone H3K4me1 strongly activates the DNase I hypersensitive sites in super-enhancers than those in typical enhancers. Kang Y, Kang J, Kim A. Biosci Rep. 2021 Jul 30;41(7). pii: 229109. doi: 10.1042/BSR20210691. PubMed |
| Histone H3K4me1 and H3K27ac play roles in nucleosome eviction and eRNA transcription, respectively, at enhancers. Kang Y, Kim YW, Kang J, Kim A. FASEB J. 2021 Aug;35(8):e21781. doi: 10.1096/fj.202100488R. PubMed |
| Genome-wide profiling in colorectal cancer identifies PHF19 and TBC1D16 as oncogenic super enhancers. Li QL, Lin X, Yu YL, Chen L, Hu QX, Chen M, Cao N, Zhao C, Wang CY, Huang CW, Li LY, Ye M, Wu M. Nat Commun. 2021 Nov 4;12(1):6407. doi: 10.1038/s41467-021-26600-5. PubMed |
| Regulation of KDM5C stability and enhancer reprogramming in breast cancer. Xiao Q, Wang CY, Gao C, Chen JD, Chen JJ, Wang Z, Ju LG, Tang SB, Yao J, Li F, Li LY, Wu M. Cell Death Dis. 2022 Oct 3;13(10):843. doi: 10.1038/s41419-022-05296-5. PubMed |
| XLID syndrome gene Med12 promotes Ig isotype switching through chromatin modification and enhancer RNA regulation. Haque F, Honjo T, Begum NA. Sci Adv. 2022 Nov 25;8(47):eadd1466. doi: 10.1126/sciadv.add1466. Epub 2022 Nov 25. PubMed |
| PRAME induces genomic instability in uveal melanoma. Harbour JW, Kurtenbach S, Sanchez M, Kuznetsoff J, Rodriguez D, Weich N, Dollar J, Cruz A, Kurtenbach S, Field M, Decatur C, Sorouri M, Lai F, Shiekhattar R, Pelaez D, Correa Z, Verdun R. Res Sq. 2023 Apr 26:rs.3.rs-2861359. doi: 10.21203/rs.3.rs-2861359/v1. Preprint. PubMed |
| Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer. Lin X, Chen JD, Wang CY, Cai Z, Zhan R, Yang C, Zhang LY, Li LY, Xiao Y, Chen MK, Wu M. Genome Biol. 2023 Nov 27;24(1):268. doi: 10.1186/s13059-023-03108-3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.